| __timestamp | Amphastar Pharmaceuticals, Inc. | Genmab A/S |
|---|---|---|
| Wednesday, January 1, 2014 | 51256000 | 850385000 |
| Thursday, January 1, 2015 | 77347000 | 1133041000 |
| Friday, January 1, 2016 | 104189000 | 1816122000 |
| Sunday, January 1, 2017 | 90795000 | 2365436000 |
| Monday, January 1, 2018 | 106985000 | 3025137000 |
| Tuesday, January 1, 2019 | 131923000 | 5366000000 |
| Wednesday, January 1, 2020 | 143340000 | 10111000000 |
| Friday, January 1, 2021 | 199739000 | 8482000000 |
| Saturday, January 1, 2022 | 248860000 | 14595000000 |
| Sunday, January 1, 2023 | 351121000 | 16248000000 |
| Monday, January 1, 2024 | 20541000000 |
Data in motion
In the competitive landscape of pharmaceuticals, understanding who leads in profitability can offer valuable insights. Over the past decade, Genmab A/S has consistently outperformed Amphastar Pharmaceuticals, Inc. in terms of gross profit. From 2014 to 2023, Genmab's gross profit surged by approximately 1,810%, reaching a peak of $16.25 billion in 2023. In contrast, Amphastar's growth, while notable, was more modest, with a 585% increase, culminating in a gross profit of $351 million in the same year.
This stark difference highlights Genmab's strategic positioning and market dominance. The data suggests that Genmab's innovative approaches and robust product pipeline have significantly contributed to its financial success. As the pharmaceutical industry continues to evolve, these insights underscore the importance of strategic investments and innovation in driving profitability.
Who Generates Higher Gross Profit? Novo Nordisk A/S or Amphastar Pharmaceuticals, Inc.
Gross Profit Comparison: Merck & Co., Inc. and Genmab A/S Trends
Gross Profit Analysis: Comparing Sanofi and Amphastar Pharmaceuticals, Inc.
Key Insights on Gross Profit: Bristol-Myers Squibb Company vs Genmab A/S
Gross Profit Comparison: Takeda Pharmaceutical Company Limited and Amphastar Pharmaceuticals, Inc. Trends
Alnylam Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Genmab A/S vs Bio-Techne Corporation: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Genmab A/S vs Jazz Pharmaceuticals plc
Who Generates Higher Gross Profit? Genmab A/S or Travere Therapeutics, Inc.
Gross Profit Comparison: Genmab A/S and Taro Pharmaceutical Industries Ltd. Trends
Gross Profit Comparison: Ascendis Pharma A/S and Amphastar Pharmaceuticals, Inc. Trends
Who Generates Higher Gross Profit? MorphoSys AG or Amphastar Pharmaceuticals, Inc.